Just as a new Alzheimer's drug comes on the market, South Carolina bike riders will brave 255 hot miles across the state to ...
U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients ...
On Tuesday, the Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer ...
that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...
There’s no cure for Alzheimer’s disease, but in the past few years, researchers have found treatments that seem to stop some ...
Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity ...
I’m so excited that we have something that actually possibly could lead to a cure. There is no cure yet. But we’re really ...
Here's why they picked Eli Lilly ( LLY 1.83%), Regeneron Pharmaceuticals ( REGN 0.99%), and Vertex Pharmaceuticals ( VRTX ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although psychedelic drug stocks have lost some of their earlier momentum, ...
Cooling economic data raised rate-cut hopes. Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in ...
Dr. Chang recruited some of the most experienced theranostics experts from around the globe to join his mission. Dr. Harshad ...
While most Americans enjoy access to marijuana, barriers to research and knowledge expansion persist—with dangerous ...